The sale of insulin is part of the state’s CalRx initiative aimed at lowering prescription drug prices for Californians.

SACRAMENTO, California — California will start selling low-cost insulin in January, becoming the first state in the nation to ...

California's first insulin pens will be for sale two years after the governor’s promised delivery date in 2024.

Civica will begin selling a type of insulin on Jan. 1, 2026, although it will not come from the nonprofit drug maker’s ...

Gov. Gavin Newsom announced Thursday that the state would provide insulin shots for $11, far below market prices.

Long-acting insulin pens will be available at pharmacies for $11 per pen — or $55 for a five-pack — beginning Jan. 1.

California will soon become the first state to offer its own affordable insulin, with Gov. Gavin Newsom announcing that CalRx ...

Biocon Biologics expands collaboration with Civica to supply affordable Insulin Glargine in the US. Aiming to improve patient ...

The FDA has accepted for review the sBLA for Afrezza (insulin human) inhalation powder in children and adolescents with type 1 or 2 diabetes.

AI tools designed to make health care more efficient are ubiquitous, though many remain piecemeal and siloed, as researchers ...

The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health ...